If you do not have health insurance, the initial appointment will be $232. Follow-up appointments will be $104.

Similar documents
DAST: Drug Abuse Screening Test

BEHAVIORAL HEALTH SCREENING TOOLS

Pocket Card SBIRT Side 1 and 2

ALCOHOL DRUG EVALUATION PREPARATION

Medical condition SELF Mother Father Sibling (list brother or sister) Anxiety Bipolar disorder Heart Disease Depression Diabetes High Cholesterol

Buprenorphine & Controlled Substance Treatment Agreement

Applicant s Name (PRINT): Applicant s Signature: Date: Anticipated Admission Date: Time: Staff Approval: Date:

NIDA Quick Screen V1.0F1

REFERRAL SOURCE GUIDELINES. Listed below is a general outline of the referral, interview and intake process at Last Door Recovery Centre.

PATIENT INTAKE: MEDICAL HISTORY. Name. Address. Phone (W) (H) (C) DOB Age SS# Emergency Contact. Relationship to patient Phone

NIDA-Modified ASSIST - Prescreen V1.0*

Screening, Identification, Counseling, and Treatment of Opioid Use Disorder

NIDA-Modified ASSIST Prescreen V1.0 1

Crossroads for Women Application

Program Application. Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree:

PATIENT INTAKE: MEDICAL AND SOCIAL HISTORY (To be completed by patient)

SBIRT Screening and Brief Assessment Questionnaires

HAVEN WOMEN S PROGRAM APPLICATION

19 TH JUDICIAL DUI COURT REFERRAL INFORMATION

WELD COUNTY ADULT TREATMENT COURT REFERRAL INFORMATION

Name: Gender: male female Age: Date of birth: / / Preferred phone: cell home work other. Alternate phone: cell home work other.

Transitional House Application

If Yes, where? Please rate severity of the pain: (low) (high)

Wasted AN INTRODUCTION TO SUBSTANCE ABUSE

COMPASS RECOVERY OPIOID REHABILITATION PROGRAM QUESTIONAIRE FOR PROSPECTIVE OPIOID REHABILITATION. Name Birthdate / /

Healthy Michigan Dental Plan Handbook

NIAGARA HEALTH SYSTEM PORT COLBORNE GENERAL SITE

WHAT I GOT FROM TREATMENT (2.0) William R. Miller & Janice M. Brown

3726 E. Hampton St., Tucson, AZ Phone (520) Fax (520)

APPLICATION FOR Page 1/8 RESIDENTIAL TREATMENT

What I Want From Treatment User Information

Driftwood Psychological Services 664 Scranton Rd., Suite 201 Brunswick, GA Phone:

Eliada Assessment Center Application for Services

PATIENT SIGNATURE: DOB: Date:

Medication Assisted Treatment Specialist - MATS

Annual Reports Questionnaire (ARQ) Part III: Extent, patterns and trends in drug use

Home and Community Based Services (HCBS)

About this consent form. Why is this research study being done? Partners HealthCare System Research Consent Form

There are no course prerequisites for this course other than being an RBA (Regents Bachelor of Arts) student.

Personalized Feedback: Where Does Your Drug Use Fit In? Individual and Group Therapy Session 1

PATIENT HISTORY DATA FORM Psychiatric, Health and Wellness, LLC 810 Michael Drive, Suite L Chesterton, IN NAME

DRUG USE LEVELS IN FRANCE IN 2010

NOW CANADA SOCIETY TUTT STREET KELOWNA, BC V1Y 8Z5 TELEPHONE (250) FAX (250)

PSYCHOLOGIST-PATIENT SERVICES

SECTION 2: CURRENT CONCERNS Briefly describe the current concerns you would like to discuss with your counselor:

PATIENT IDENTIFICATION: Name: First Appointment Date: Birth Date: Address: City State Zip Home Phone #: Work #: Cell #: REFERRAL SOURCE: Referred By:

Opioid Treatment Center Application

About this consent form

Substance Abuse. Heather Gotham, PhD, Licensed Clinical Psychologist September 9, TB Nurse Case Management September 7-9, 2016 San Antonio, TX

COLLEGIATE RECOVERY PROGRAM APPLICATION

A HEALING ALTERNATIVE COUNELING AND WELLNESS CENTER, LLC

SUBOXONE FILM NEW PATIENT INTRODUCTION

Narrative Report - ASI-MV Addiction Severity Index - Multimedia Version

AN INTRODUCTION TO THE TREATMENT OF OPIOID USE DISORDERS IN PRIMARY CARE

If so, when: Demographic Information Male Transgender Height: Weight: Massachusetts Resident? Primary Language: Are you currently homeless?

The data were expressed as descriptive frequencies and percentages.

Counseling Service Personal Information Form. Name: Preferred Name: Can your preferred name be updated for all LC Health and Wellness offices?

Top of the World Ranch Treatment Centre Admissions Information Record Demographics

PLEASE PRINT PLEASE CHECK THE BOX AFTER THE PHONE NUMBER THAT YOU WANT AS YOUR PREFERRED NUMBER

McLean Ambulatory Treatment Center Adult Partial Hospital and Residential Program for Alcohol and Drug Abuse 115 Mill Street Belmont, MA 02478

5975 Parkway North Blvd., Suite D 3060 Royal Blvd. South, Suite 110 Cumming, GA Alpharetta, GA 30022

APPLICATION FOR ADMISSION (PLEASE PRINT CLEARLY)

75 % = = LOW-RISK DRINKING LIMITS Source: National Institutes of Health WHAT COUNTS AS ONE DRINK? RISK ZONE PYRAMID 10 %

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

Structured Clinical Interview on Money Mismanagement (SCIMM)

The college will enforce the following regulations, regardless of the status of court decisions:

Fighting Today s Opioid Epidemic

problems/medications: Current supplements/vitamins/herbs: Past medical problems/medications: Other doctors/clinics seen regularly:

PATIENT REGISTRATION FORM

COMMON REFERRAL FORM

CMBHS Clinical Management of Behavioral Health Services

BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH

Physical Issues: Emotional Issues: Legal Issues:

Substance Prevention

APPLICATION FOR ADMISSION

Presentation to PPI Thursday 17 th May 2012 GILL HESSION - Manager. Appendix 1

ECHO Screening and Assessment

Substance-Exposed Newborns

Substance Abuse Policy. Substance Abuse Policy for Employees and Students

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

Pro Active Physical Therapy & Sports Medicine

Home Sleep Test (HST) Instructions

NICOLET COLLEGE LAW ENFORCEMENT ACADEMY BACKGROUND QUESTIONAIRE

AVON COMMUNITY SCHOOLS AVON MIDDLE SCHOOL SOUTH DRUG TESTING PROCEDURES AND GUIDELINES REASONABLE SUSPICION AND RANDOM DRUG TESTING

EXODUS HOMES RESIDENT APPLICATION

Title of Research Study: Discovery and Validation of Biomarkers for Lichen Sclerosus

The Johns Hopkins Bloomberg School of Public Health

Preferred Practice Guidelines for the Evaluation and Treatment of Bipolar Disorder

Effective Date: 9/14/06 NOTICE PRIVACY RULES FOR VALUEOPTIONS

SUBOXONE TREATMENT PROGRAM

Clinical Guidelines and Coverage Limitations for Medication Assisted Treatment (MAT)

Please list medications and dosage (including non-prescriptions) you are currently taking or have taken recently:

9/9/2016. Drug Name (select from list of drugs shown) Bunavail Buccal Film (buprenorphinenaloxone) Suboxone Sublingual Film (buprenorphine-naloxone)

We are inviting you to participate in a research study/project that has two components.

Clinical Genetics Service

Sample Process Flow and Quality Assurance Checklist for Immigration Physicals

DEKALB COUNTY GOVERNMENT DRUG-FREE WORKPLACE POLICY

Welcome to the second module of the Screening, Brief Intervention, and Referral to Treatment Core Curriculum. In this module, we ll address screening

OFFICIAL POLICY. Policy Statement

We are inviting you to participate in a research study/project that has two components.

Transcription:

APPLICATION FOR ADMISSION TO ADDICTION MEDICINE PROGRAM AT MARQUETTE GENERAL BEHAVIORAL HEALTH SERVICES FOR BUPRENORPHINE (Suboxone) THERAPY In order to be considered for admission to the Addiction Medicine Program for Buprenorphine (Suboxone) therapy at Marquette General Behavioral Health Services, you must first complete the enclosed application. This application includes: 1) Application for Admission (this form) 2) Personal Data Form 3) Summary of Chemical Use 4) Treatment Contract for Suboxone (Buprenorphine) Therapy All applicants must be actively involved in substance abuse counseling in order to be considered for admission. Applications returned without a copy of a substance abuse assessment and letter from a current addiction counselor, recommending treatment with buprenorphine, will automatically be rejected. Please be aware that we have a very limited number of patients that we can accept for treatment with buprenorphine. Applications will be reviewed against established criteria to identify patients who are most likely able to benefit from treatment with buprenorphine. It is absolutely essential that you carefully and completely answer all questions. Incomplete applications will automatically be rejected. You can expect one of three possible responses within 2-4 weeks of our receipt of the application: 1) Invitation to meet with the physician for a medical exam and interview. 2) Letter notifying you that your application has been denied. 3) Notification that you have been placed on a waiting list. The invitation to meet with the physician does not mean that you have been accepted into the program. The final determination for eligibility to receive treatment with buprenorphine is made at the appointment with the physician. Fees/Costs: Marquette General Behavioral Health Services is able to accept most forms of public and private health insurance to cover costs. You will be made aware of any co-pays or deductibles prior to your first visit. Payment is due at the time of service. If you do not have health insurance, the initial appointment will be $232. Follow-up appointments will be $104. You can expect to be paying anywhere from $16 - $20 (or more, depending on dosage) per day for the buprenorphine. 1

SCREENING QUESTIONNAIRE Name: DOB: Today s Date: Mailing Address: Phone/Cell Number: Can we contact you by phone? yes no Can we leave a message? yes no Insurance: Please provide the name of our substance abuse counselor and agency. Contact your substance abuse counselor and request a copy of your assessment and a letter of referral. Include these items with this application. Please answer the following questions: If enough space is not provided for your answer, attach additional pages or write on back. 1) Why are you interested in buprenorphine treatment and what are your treatment goals? To be clean and sober (off all drugs and alcohol) To be clean from opiates/narcotics Other (please describe your goal) 2) Are you currently using any illicit (illegal or non-prescribed) drugs or alcohol? If so, what are you using and how much? 3) Are you currently being prescribed buprenorphine? yes no If yes, please provide name of prescribing physician: 4) Have you ever been legally prescribed buprenorphine? yes no If yes, a. Name of physician: b. Dates that you were prescribed buprenorphine: (start and stop dates) c. Reason for discontinuing: 2

5) Are you currently in a Methadone program? yes no If yes, please contact prescribing physician and request a letter of referral. Include this with the application. 6) Are you currently being treated for any medical problems? yes no If yes, list medical problems and physician/s providing treatment 7) Are you enrolled in the Michigan Marihuana Program? yes no I have applied, or plan to apply, for enrollment. 8) Are you currently being treated for any mental health or psychiatric problems? yes no If yes, what are you being treated for and who is providing treatment? 9) Females: Are you pregnant? yes no not sure 10) Have you ever been told you have Hepatitis or that your liver enzymes are elevated? yes no 11) Is anyone in your home actively addicted to alcohol/drugs? If yes, who? 12) What supports do you have for your recovery? 13) Is there any additional information that you would like us to know in consideration of your application? (Use separate sheet of paper or write on back, if necessary.) 3

Drug Abuse Screening Test (DAST-10), Drug Use Questionnaire The following questions concern information about your possible involvement with drugs not including alcoholic beverages during the past 12 months. Carefully read each statement and decide if your answer is Yes or No. Then circle the appropriate response beside the question. In the following statements drug abuse refers to The use of prescribed or over-the-counter drugs in excess of the directions, and Any nonmedical use of drugs. The various classes of drugs may include cannabis (e.g., marijuana, hashish), solvents (e.g., paint thinner), tranquilizers (e.g., Valium), barbiturates, cocaine, stimulants (e.g., speed), hallucinogens (e.g., lysergic acid diethylamide [LSD]), or narcotics (e.g., heroin). Remember that the questions do not include alcoholic beverages. Please answer every question. If you have difficulty with a question, then choose the response that is mostly right. These Questions Refer to the Past 12 Months 1. Have you used drugs other than those required for medical reasons? Yes No 2. Do you abuse more than one drug at a time? Yes No 3. Are you always able to stop using drugs when you want to? Yes No 4. Have you ever had blackouts or flashbacks as a result of drug use? Yes No 5. Do you ever feel bad or guilty about your drug use? Yes No 6. Does your spouse (or parents) ever complain about your involvement with Yes No drugs? 7. Have you neglected your family because of your use of drugs? Yes No 8. Have you engaged in illegal activities in order to obtain drugs? Yes No 9. Have you ever experienced withdrawal symptoms (felt sick) when you Yes No stopped taking drugs? 10. Have you had medical problems as a result of your drug use (e.g., memory Yes No loss, hepatitis, convulsions, bleeding)? Send Completed Applications to: Patricia Ellison, CADC Marquette General Behavioral Health 580 W. College Ave. Marquette, MI 49855 4

Checklist for Application: Application (this form) Personal Data Form Summary of Chemical Use Treatment Contract Letter of Referral and Records from Substance Abuse Service Provider. If APPLICABLE: Letters of Referral and Records from Physician Currently Prescribing Methadone or Buprenorphine 5